Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program - PubMed (original) (raw)
Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program
Joaquim Soler et al. Front Pharmacol. 2018.
Erratum in
- Corrigendum: Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study with a Standard 8-Week Mindfulness Training Program.
Soler J, Elices M, Dominguez-Clavé E, Pascual JC, Feilding A, Navarro-Gil M, Garcia-Campayo J, Riba J. Soler J, et al. Front Pharmacol. 2021 Jan 21;11:635111. doi: 10.3389/fphar.2020.635111. eCollection 2020. Front Pharmacol. 2021. PMID: 33551823 Free PMC article.
Abstract
Background: The therapeutic effects of the Amazonian plant tea ayahuasca may relate to its ability to enhance mindfulness capacities. Ayahuasca induces a modified state of awareness through the combined action of its active principles: the psychedelic _N,N-_dimethyltryptamine (DMT) and a series of centrally acting β-carbolines, mainly harmine and tetrahydroharmine. To better understand the therapeutic potential of ayahuasca, here we compared the impact on mindfulness capacities induced by two independent interventions: (a) participation in four ayahuasca sessions without any specific purpose related to improving mindfulness capacities; and (b) participation in a standard mindfulness training course: 8 weeks mindfulness-based stress reduction (MBSR), with the specific goal of improving these skills. Methods: Participants of two independent groups completed two self-report instruments: The Five Facet Mindfulness Questionnaire (FFMQ) and the Experiences Questionnaire (EQ). The MINDSENS Composite Index was also calculated, including those EQ and FFMQ items that have proven to be the most sensitive to meditation practice. Group A (n = 10) was assessed before and after the last of four closely spaced consecutive ayahuasca sessions. Group B (n = 10) was assessed before and after completion of a standard 8-week MBSR course. Results: MBSR training led to greater increases in overall mindfulness scores after the 8-week period. MBSR but not ayahuasca led to increases in the MINDSENS Composite Index. However, the ayahuasca sessions induced comparable increases in the Non-Judging subscale of the FFMQ, specifically measuring "acceptance." Improving this capacity allows for a more detached and less judgmental stance toward potentially distressing thoughts and emotions. Results: The present findings suggest that a small number of ayahuasca sessions can be as effective at improving acceptance as more lengthy and costly interventions. Future studies should address the benefits of combining ayahuasca administration with mindfulness-based interventions. This will allow us to investigate if ayahuasca will improve the outcome of psychotherapeutic interventions.
Keywords: Non-Judging; acceptance; ayahuasca; human; mindfulness.
Figures
FIGURE 1
Pre–post changes in FFMQ facets and decentering scores (Experiences Questionnaire) in group A (ayahuasca intake) and group B (mindfulness training). Values are shown as means with standard errors represented by vertical bars.
Similar articles
- Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.
Soler J, Elices M, Franquesa A, Barker S, Friedlander P, Feilding A, Pascual JC, Riba J. Soler J, et al. Psychopharmacology (Berl). 2016 Mar;233(5):823-9. doi: 10.1007/s00213-015-4162-0. Epub 2015 Nov 27. Psychopharmacology (Berl). 2016. PMID: 26612618 - Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits.
Domínguez-Clavé E, Soler J, Pascual JC, Elices M, Franquesa A, Valle M, Alvarez E, Riba J. Domínguez-Clavé E, et al. Psychopharmacology (Berl). 2019 Feb;236(2):573-580. doi: 10.1007/s00213-018-5085-3. Epub 2018 Nov 7. Psychopharmacology (Berl). 2019. PMID: 30406413 - Corrigendum: Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study with a Standard 8-Week Mindfulness Training Program.
Soler J, Elices M, Dominguez-Clavé E, Pascual JC, Feilding A, Navarro-Gil M, Garcia-Campayo J, Riba J. Soler J, et al. Front Pharmacol. 2021 Jan 21;11:635111. doi: 10.3389/fphar.2020.635111. eCollection 2020. Front Pharmacol. 2021. PMID: 33551823 Free PMC article. - Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
Domínguez-Clavé E, Soler J, Elices M, Pascual JC, Álvarez E, de la Fuente Revenga M, Friedlander P, Feilding A, Riba J. Domínguez-Clavé E, et al. Brain Res Bull. 2016 Sep;126(Pt 1):89-101. doi: 10.1016/j.brainresbull.2016.03.002. Epub 2016 Mar 11. Brain Res Bull. 2016. PMID: 26976063 Review. - Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,_N_-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact.
Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM, Dinis-Oliveira RJ, Madureira-Carvalho Á. Brito-da-Costa AM, et al. Pharmaceuticals (Basel). 2020 Oct 23;13(11):334. doi: 10.3390/ph13110334. Pharmaceuticals (Basel). 2020. PMID: 33114119 Free PMC article. Review.
Cited by
- Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors.
Jiwani Z, Goldberg SB, Stroud J, Young J, Curtin J, Dunne JD, Simonsson O, Webb CA, Carhart-Harris R, Schlosser M. Jiwani Z, et al. medRxiv [Preprint]. 2024 Aug 28:2024.08.27.24312677. doi: 10.1101/2024.08.27.24312677. medRxiv. 2024. PMID: 39252913 Free PMC article. Preprint. - Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.
Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D'Souza DC. Sloshower J, et al. Sci Rep. 2024 Apr 17;14(1):8833. doi: 10.1038/s41598-024-58318-x. Sci Rep. 2024. PMID: 38632313 Free PMC article. Clinical Trial. - The Effects of Ayahuasca on Psychological Disorders: A Systematic Literature Review.
Sheth R, Parikh E, Olayeye K, Pfeifer K, Khanna D. Sheth R, et al. Cureus. 2024 Mar 5;16(3):e55574. doi: 10.7759/cureus.55574. eCollection 2024 Mar. Cureus. 2024. PMID: 38576633 Free PMC article. Review. - Psychiatric risks for worsened mental health after psychedelic use.
Marrocu A, Kettner H, Weiss B, Zeifman RJ, Erritzoe D, Carhart-Harris RL. Marrocu A, et al. J Psychopharmacol. 2024 Mar;38(3):225-235. doi: 10.1177/02698811241232548. Epub 2024 Mar 4. J Psychopharmacol. 2024. PMID: 38491857 Free PMC article. Review. - The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. Zaretsky TG, et al. Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147. Curr Neuropharmacol. 2024. PMID: 38284341 Free PMC article. Review.
References
- Bishop S. R., Lau M., Shapiro S., Carlson L., Anderson N. D., Carmody J., et al. (2004). Mindfulness: a proposed operational definition. Clin. Psychol. Sci. Pract. 11 230–241. 10.1093/clipsy.bph077 - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources